Detection of P glycoprotein activity on normal and leukemic CD34+ cells
Authors:
- Olivier FardelOFOlivier Fardel
- Laurence AmiotLALaurence Amiot
- Renée FauchetRFRenée Fauchet
- 1 December 1993
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 17 (12) , 1031-1035
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Blood, 1993
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Multidrug resistance activity in human lymphocytesHuman Immunology, 1991
- Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivityBlood, 1991
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Multidrug ResistanceAnnual Review of Medicine, 1991
- MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaBritish Journal of Haematology, 1990
- Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selectionExperimental Cell Research, 1989
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976